Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1372-1377

  Baffa, Raffaele ^a   Santoro, Roberto ^b   Bullrich, Florencia ^a   Mandes, Bernadette ^a   Ishii, Hideshi ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 8P; CHROMOSOME DELETION; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; STOMACH NEOPLASMS;

EID: 0034007138     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 49: 8-31, 1999.
2. Santoro, E., Carlini, M., Garofalo, A., Carboni, F., Santoro, R., and Castelli, M. Gastric cancer. Clinical biological updating and analysis of 400 operated cases. J. Exp. Clin. Cancer Res., 17: 175-185, 1998.
3. Siewert, J. R., Bottcher, K., Stein, H. J., and Roder, J. D. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann. Surg., 228: 449-461, 1998.
4. Bonenkamp, J. J., Hermans, J., Sasako, M., and van de Velde, C. J. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N. Engl. J. Med., 24: 908-914, 1999.
5. Kinoshita, T., Maruyama, K., Sasako, M., and Okajima, K. Treatment results of gastric cancer patients: Japanese experience. In: M. Nishi, H. Schkawa, T. Nokajima, K. Maruyama, and E. Tahara (eds.), Gastric Cancer, pp. 80-87. Tokyo: Springer-Verlag Tokyo, 1993.
6. De Stefani, E., Boffetta, P., Mendilaharsu, M., Carzoglio, J., and Deneo-Pellegrini, H. Dietary nitrosamines, heterocyclic amines, and risk of gastric cancer: a case-control study in Uruguay. Nutr. Cancer, 30: 158-162, 1998.
7. Tahara, E. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Exp. Toxicol. Pathol., 50: 375-378, 1998.
8. Correa, P. Helicobacter pylori as a pathogen and carcinogen. J. Physiol. Pharmacol., 48: 19-24, 1997.
9. Forbes, G. M., and Threlfall, T. J. Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: uncertain benefits of a community-based programme in Australia. J. Gastrenterol. Hepatol., 13: 1091-1095, 1998.
10. Luinetti, O., Fiocca, R., Villani, L., Alberizzi, P., Ranzani, G. N., and Solcia, E. Genetic pattern, histological structure, and cellular phenotype in early and advanced gastric cancers: evidence for structure-related genetic subsets and for loss of glandular structure during pro-gression of some tumors. Hum. Pathol., 29: 702-709, 1998.
11. Weinberg, R, A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
12. Knudson, A. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
13. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
14. Tahara, E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer (Phila.), 75: 1410-1417, 1995.
15. Shiao, Y. H., Palli, D., Buzard, G. S., Caporaso, N. E., Amorosi, A., Saieva, C., Fraumeni, J. F., Jr., Anderson, L. M., and Rice, J. M. Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy. Carcinogenesis (Lond.), 19: 2145-2149, 1998.
16. Tolbert, D. M., Noffsinger, A. E., Miller, M. A., DeVoe, G. W., Stemmermann, G. N., Macdonald, J. S., and Fenoglio-Preiser, C. M. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Mod. Pathol., 12: 54-60, 1999.
17. Igaki, H., Sasaki, H., Tachimori, Y., Kato, H., Watanabe, H., Kimura, T., Harada, Y., Sugimura, T., and Terada, M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55: 3421-3423, 1995.
18. Gunther, T., Schneider-Stock, R., Pross, M., Manger, T., Malfertheiner, P., Lippert, H., and Roessner, A. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer. Pathol. Res. Pract., 194: 809-813, 1998.
19. Hara. T., Ooi, A., Kobayashi, M., Mai, M., Yanagihara, K., and Nakanishi, I. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab. Investig., 78: 1143-1153, 1998.
20. Tsuchiya, C., Ohshima, S., and Takahama, M. Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials. J. Gastroenterol., 32: 28-33, 1997.
21. Baffa, R., Veronese, M. L., Santoro, R., Mandes, B., Palazzo, J. P., Rugge, M., Santoro, E., Croce, C. M., and Huebner, K. Loss of FHIT expression in gastric carcinoma. Cancer Res., 58: 4078-4014, 1998.
22. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphee, A. L., Strong, L. C., and White, R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784, 1983.
23. Lasko, D., and Cavenee, W. K. Loss of constitutional heterozygosity in human cancer. Annu. Rev. Genet., 25: 281-314, 1991.
24. Bodmer, W. F., Bailey, C. J., Bodmer, J., Bussey, H. J., Ellis, A., Gorman, P., Lucibello, F. C., Murday, V. A., Rider, S. H., Scambler, P., Sheer, D., Solomon, E., and Spurr, N. K. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature (Lond.), 328: 614-616, 1987.
25. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., van Tuinen, P., Ledbetter, D. H., Baker, D. F., Nakamura, Y., White, R. L., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
26. Fearon, E. R., Cho, K. R., Nigro, J. M., Kern. S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., and Vogelstein, B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247: 49-56, 1990.
27. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J. P., Siprashvili, Z., Mod, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated translocation breakpoint, is abnormal in digestive tract cancer. Cell, 84: 587-597, 1996.
28. Kastury, K., Baffa, R., Druck, T., Ohta, M., Cotticelli, M. G., Inoue, H., Negrini, M., Rugge, M., Huang, D., Croce, C. M., Palazzo, J. P., and Huebner, K. Potential gastrointestinal tumor suppressor locus at 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res., 56: 978-983, 1996.
29. Macoska, J. A., Trybus, T. M., Benson, P. D., Sakr, W. A., Grignon, D. J., Wojno, K. D., Pietruk, T., and Powell, I. J. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res., 55: 5390-5395, 1995.
30. Fujiwara, Y., Emi, M., Ohata, H., Kato, Y., Nakajima, T., Mori, T., and Nakamura, Y. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res., 53: 1172-1174, 1993.
31. Farrington, S. M., Cunningham, C., Boyle, S. M., Wyllie, A. H., and Dunlop, M. G. Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumor suppressor loci involved in colorectal cancer. Oncogene, 12: 1803-1808, 1996.
32. Vocke, C. D., Pozzatti, R. O., Bostwick, D. G., Florence, C. D., Jennings, S. B., Strup, S. E., Duray, P. H., Liotta, L. A., Emmert-Buck, M. R., and Linehan, W. M. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res., 56: 2411-2416, 1996.
33. 0 prostate cancer. Genes Chromosomes Cancer, 21: 131-143, 1998.
34. Suzuki, H., Emi, M., Komiya, A., Fujiwara, Y., Yatani, R., Nakamura, Y., and Shimazaki, J. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosomes Cancer, 13: 168-174, 1995.
35. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
36. Kagan, J., Stein, J., Babaian, R. J., Joe, Y. J., Pisters, L. L., Glassman, A. B., von Eschenbach, A. C., and Troncoso, P. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene, 11: 2121 -2126, 1995.
37. Ishii, H., Baffa, R., Numata, S., Murakumo, Y., Rattan, S., Inoue, H., Mori, M., Fidanza, V., Alder, H., and Croce, C. M. The FEZI gene at chromosome 8p22 encodes a leucin-zipper protein, and its expression is altered in multiple human tumors. Proc. Natl. Acad. Sci. USA, 96: 3928-3933, 1999.
38. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Birnbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
39. Anbazhagan, R., Fujii, H., and Gabrielson, E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am. J. Pathol., 752: 815-819, 1998.
40. El-Naggar, A. K., Coombes, M. M., Batsakis, J. G., Hong, W. K., Goepfert, H., and Kagan, J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene, 16: 2983-2987, 1998.
41. Takle, L. A., and Knowles, M. A. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene, 12: 1083-1087, 1996.
42. Boige, V., Laurent-Puig, P., Fouchet, P., Flejou, J. F., Monges, G., Bedossa, P., Bioulac-Sage, P., Capron, F., Schmitz, A., Olschwang, S., and Thomas, G. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res., 57: 1986-1990, 1997.
43. Wright, K., Wilson, P. J., Kerr, J., Do, K., Hurst, T., Khoo, S. K., Ward, B., and Chenevix-Trench, G. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Oncogene, 17: 1185-1188, 1998.
44. Ohata, H., Emi, M., Fujiwara, Y., Higashino, K., Nakagawa, K., Futagami, R., Tsuchiya, E., and Nakamura, Y. Deletion mapping of the short arm of chromosome 8 in non-small cell lung cancer. Genes Chromosomes Cancer, 7: 85-88, 1993.
45. Wistuba, I. I., Behrens, C., Virmani, A. K., Milchgrub, S., Syed, S., Lam, S., Mackay, B., Minna, J. D., and Gazdar, A. F. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res., 59: 1973-1979, 1999.
46. Takeuchi, S., Bartram, C. R., Wada, M., Reiter, A., Hatta, Y., Seriu, T., Lee, E., Miller, C. W., Miyoshi, I., and Koeffler, H. P. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res., 55: 5377-5382, 1995.
47. Hubbard, A., Harrison, D. J., Moyes, C., Wyllie, A. H., Cunningham, C., Mannion, E., and Smith, C. A. N-Acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut, 41: 229-234, 1997.
48. Fujiwara, Y., Ohata, H., Kuroki, T., Koyama, K., Tsuchiya, E., Monden, M., and Nakamura, Y. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extra-cellular domain of the PDGF receptor β gene. Oncogene, 10: 891-895, 1995.
49. Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res., 52: 5368-5372, 1992.
50. Yustein, A. S., Harper, J. C., Petroni, G. R., Cummings, O. W., Moskaluk, C. A., and Powell, S. M. Allelotype of gastric adenocarcinoma. Cancer Res., 59: 1437-1441, 1999.
51. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
52. Baffa, R., Negrini, M., Mandes, B., Rugge, M., Ranzani, G. N., Hirohashi, S., and Croce, C. M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res., 56: 268-272, 1995.
53. Bookstein, R., Levy, A., MacGrogan, D., Lewis, T. B., Weissenbach, J., O'Connel, P., and Leach, R. J. Yeast artificial chromosome and radiation hybrid map of loci in chromosome band 8p22, a common region of allelic loss in multiple human cancers. Genomics, 24: 317-323, 1994.
54. Ichikawa, T., Nihei, N., Suzuki, H., Oshimura, M., Emi, M., Nakamura, Y., Hayata, I., Isaacs, J. T., and Shimazaki, J. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res., 54: 2299-2302, 1994.
55. Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Konishi, M., Oshimura, M., and Miyaki, M. Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8p12-pter. Oncogene, 12: 405-410, 1996.
56. Bookstein, R., Bova, G. S., MacGrogan, D., Levy, A., and Isaacs, W. B. Tumor-suppressor genes in prostatic oncogenesis: a positional approach. Br. J. Urol., 79: 28-36, 1997.